Gen Digital Inc. (GEN) fair value analysis

S&P 500 & Nasdaq · Updated 2026-09-07

Gen Digital Inc. is a technology company that develops and sells security and privacy software products designed to protect consumers and businesses from cybersecurity threats. The company operates globally and serves customers across multiple continents through its various software platforms and services.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, GEN is trading at a 10–25% discount to estimated fair value.

GEN currently ranks #91 of 199 Technology stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $30.65
Sector: Technology
12-month range: $18.71–$30.02

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: B
Momentum grade: A
Leverage: High
Margin trend: Stable
Revenue growth: Strong
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The top quarter of its range
DCF cross-check: Undervalued

What our data shows for GEN

Our model validated 17 trailing price-to-earnings windows for GEN, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $18.71–$30.02.
The 14-day relative strength index sits at a neutral 61.
3 of the last 12 weekly snapshots showed positive price momentum.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for GEN
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent GEN news

TickrTrends' derived news-sentiment signal for GEN is currently leaning positive, computed from recent coverage.

Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care (manilatimes.net, 2025-12-19)
TickrTrends take: Genesis Healthcare operates in the Technology sector and carries an Undervalued designation according to TickrTrends' current analysis. Third-party recognition of the company's skilled nursing care standards may support operational credibility, though valuation investors should monitor whether such external validation translates into measurable improvements in financial metrics or market positioning. For those tracking GEN through a valuation lens, evidence of sustained quality benchmarks could become relevant to future reassessments of the company's fundamental value proposition.
Genesis Healthcare Remains Committed to Securing Longterm Stability (manilatimes.net, 2025-12-12)
TickrTrends take: Genesis Healthcare's stated commitment to long-term stability suggests management focus on fundamental operational health rather than short-term value extraction, which aligns with TickrTrends' undervalued assessment in the Technology sector. Investors monitoring this position should observe whether stability-focused initiatives translate into concrete improvements in financial metrics and cash generation, as these improvements would support the undervalued thesis. The company's messaging around durability indicates management may be positioning for sustainable value creation, making execution on stated commitments a key factor for valuation-focused readers to track.
79-year-old key health care provider files Chapter 11 bankruptcy (finance.yahoo.com, 2025-10-09)
TickrTrends take: A major healthcare provider's Chapter 11 filing introduces operational uncertainty that could affect companies in the technology sector that serve healthcare customers, including GEN. Valuation-focused investors monitoring GEN should track whether this bankruptcy creates disruptions to GEN's healthcare-related business relationships or revenue streams. TickrTrends currently marks GEN as undervalued, so investors may want to assess how this industry event impacts the company's competitive position and financial outlook relative to that valuation view.

What people are saying

Follow the GEN conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — # GEN Stock Research Update TickrTrends' derived indicators for GEN in the Technology sector have shifted this week, with the DCF cross-check band moving from an overvalued assessment to an undervalued one. This change aligns with the current valuation verdict of undervalued. The shift in the DCF analysis suggests that recent price movements or updated financial projections have resulted in a more favorable valuation profile for the stock relative to its intrinsic value estimates.
2026-09-06 — TickrTrends' derived indicators for GEN showed modest shifts this week within the Technology sector. The Relative Strength Index moved from overbought territory into the neutral zone, while the sector discount ranking improved from 96th position to 91st position. GEN maintains an undervalued valuation verdict according to current assessment metrics.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is GEN stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), GEN is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is GEN's TickrTrends verdict?

GEN's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does GEN compare to other Technology stocks?

GEN ranks #91 of 199 Technology stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is GEN overbought or oversold?

GEN's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Technology fair-value coverage →

Head-to-head comparisons

GEN vs APH · GEN vs CEVA · GEN vs ENTG · GEN vs LYFT · GEN vs OTEX